Z17.21 – Progesterone receptor positive status

ICD-10-CM 2027 diagnosis code · Estrogen, and other hormones and factors receptor status (Z17)

Billable code

ICD-10-CM code Z17.21
Code
Z17.21 (claims format: Z1721)
Description
Progesterone receptor positive status
Billable
Yes – valid for HIPAA-covered transactions
Valid for
Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter
21. Factors influencing health status and contact with health services (Z00-Z99)
Block
Z17 Estrogen, and other hormones and factors receptor status (Z17)
Parent codes
Z17 › Z17.2

Notes for Z17.21

Applicable to:
  • PR+

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

Z17 – Estrogen, and other hormones and factors receptor status

Code first:
  • malignant neoplasm, such as:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of ovary (C56.-)
Notes:

Index terms for Z17.21

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in Z17.2

Frequently asked questions

What is ICD-10 code Z17.21?

Z17.21 is the ICD-10-CM code for progesterone receptor positive status, in the block Z17 (Estrogen, and other hormones and factors receptor status (Z17)).

Is Z17.21 a billable code?

Yes. Z17.21 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does Z17.21 belong to?

It belongs to category Z17 – Estrogen, and other hormones and factors receptor status.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.